Literature DB >> 17707983

Thia fatty acids with the sulfur atom in even or odd positions have opposite effects on fatty acid catabolism.

Endre Dyroy1, Hege Wergedahl, Jon Skorve, Oddrun A Gudbrandsen, Jon Songstad, Rolf K Berge.   

Abstract

As tools for mechanistic studies on lipid metabolism, with the long-term goal of developing a drug for the treatment of lipid disorders, thia FA with the sulfur atom inserted at positions 3-9 from the carboxyl group were fed to male Wistar rats for 1 wk to determine their impact on key parameters in lipid metabolism and hepatic levels of thia FA metabolites. Thia FA with the sulfur atom in even positions decreased hepatic and cardiac mitochondrial beta-oxidation and profoundly increased hepatic and cardiac TAG levels. The plasma TAG level was unchanged and the hepatic acyl-CoA oxidase activity increased. In contrast, thia FA with the sulfur atom in odd positions, especially 3-thia FA, tended to increase hepatic and cardiac FA oxidation and acyl-CoA oxidase and carnitine palmitoyltransferase-II activities, and decreased the plasma TAG levels. The effects seem to be related to differences in the catabolic rate of the thia FA. Differences between the two groups of acids were also observed with respect to the regulation of genes involved in FA transport and catabolism. Feeding experiments with 3- and 4-thia FA in combination indicated that the 4-thia FA partly attenuated the effects of the 3-thia FA on mitochondrial FA oxidation and the hepatic TAG level. In summary, the position of the sulfur atom in the alkyl chain, especially whether it is placed in the even or odd position, is crucial for the biological effect of the thia FA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17707983     DOI: 10.1007/s11745-006-5085-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  36 in total

1.  Long-term effect of tetradecylthioacetic acid: a study on plasma lipid profile and fatty acid composition and oxidation in different rat organs.

Authors:  D K Asiedu; L Frøyland; H Vaagenes; O Lie; A Demoz; R K Berge
Journal:  Biochim Biophys Acta       Date:  1996-04-19

2.  Morphologic effects of sulfur-substituted fatty acids on rat hepatocytes with special reference to proliferation of peroxisomes and mitochondria.

Authors:  H Kryvi; A Aarsland; R K Berge
Journal:  J Struct Biol       Date:  1990-05       Impact factor: 2.867

Review 3.  Thia fatty acids, metabolism and metabolic effects.

Authors:  S Skrede; H N Sørensen; L N Larsen; H H Steineger; K Høvik; O S Spydevold; R Horn; J Bremer
Journal:  Biochim Biophys Acta       Date:  1997-01-21

4.  Effects of thia-substituted fatty acids on mitochondrial and peroxisomal beta-oxidation. Studies in vivo and in vitro.

Authors:  R Hovik; H Osmundsen; R Berge; A Aarsland; S Bergseth; J Bremer
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

5.  Microsomal oxidation of dodecylthioacetic acid (a 3-thia fatty acid) in rat liver.

Authors:  E Hvattum; S Bergseth; C N Pedersen; J Bremer; A Aarsland; R K Berge
Journal:  Biochem Pharmacol       Date:  1991 Mar 15-Apr 1       Impact factor: 5.858

6.  The metabolic effects of thia fatty acids in rat liver depend on the position of the sulfur atom.

Authors:  Oddrun Anita Gudbrandsen; Endre Dyrøy; Pavol Bohov; Jon Skorve; Rolf K Berge
Journal:  Chem Biol Interact       Date:  2005-06-30       Impact factor: 5.192

7.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

8.  Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy.

Authors:  J Fredriksen; T Ueland; E Dyrøy; B Halvorsen; K Melby; L Melbye; B S Skalhegg; P Bohov; J Skorve; R K Berge; P Aukrust; S S Frøland
Journal:  Eur J Clin Invest       Date:  2004-10       Impact factor: 4.686

9.  Isolation and characterization of cDNA for human 120 kDa mitochondrial 2,4-dienoyl-coenzyme A reductase.

Authors:  K T Koivuranta; E H Hakkola; J K Hiltunen
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

10.  Fatty acid metabolism in liver of rats treated with hypolipidemic sulphur-substituted fatty acid analogues.

Authors:  D Asiedu; A Aarsland; J Skorve; A M Svardal; R K Berge
Journal:  Biochim Biophys Acta       Date:  1990-05-22
View more
  5 in total

1.  Synthesis and antifungal properties of alpha-methoxy and alpha-hydroxyl substituted 4-thiatetradecanoic acids.

Authors:  Néstor M Carballeira; Rosann O'Neill; Keykavous Parang
Journal:  Chem Phys Lipids       Date:  2007-06-28       Impact factor: 3.329

2.  Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice.

Authors:  Bodil Bjørndal; Eva Katrine Alterås; Carine Lindquist; Asbjørn Svardal; Jon Skorve; Rolf K Berge
Journal:  Nutr Metab (Lond)       Date:  2018-01-29       Impact factor: 4.169

3.  Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice.

Authors:  Rolf K Berge; Bodil Bjørndal; Elin Strand; Pavol Bohov; Carine Lindquist; Jan Erik Nordrehaug; Asbjørn Svardal; Jon Skorve; Ottar Nygård
Journal:  Lipids Health Dis       Date:  2016-02-05       Impact factor: 3.876

4.  Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD+/NADH ratio.

Authors:  Rolf K Berge; Daniel Cacabelos; Rosa Señarís; Jan Erik Nordrehaug; Ottar Nygård; Jon Skorve; Bodil Bjørndal
Journal:  Lipids Health Dis       Date:  2020-05-14       Impact factor: 3.876

5.  The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL.

Authors:  Thomas Lundåsen; Matteo Pedrelli; Bodil Bjørndal; Björn Rozell; Raoul V Kuiper; Lena Burri; Chiara Pavanello; Marta Turri; Jon Skorve; Rolf K Berge; Stefan E H Alexson; Veronika Tillander
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.